Johnson & Johnson Doses At Risk Of Expiring As FDA Mulls Extension

The FDA’s decision to pause distribution of the one-dose vaccine is credited with damaging its reputation among Americans.

Add a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.